Metazosin is an antihypertensive α1-adrenergic receptor antagonist.[1][2]

Metazosin
Names
IUPAC name
1-[4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-2-methoxypropan-1-one
Other names
Kenosin
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C18H25N5O4/c1-11(25-2)17(24)22-5-7-23(8-6-22)18-20-13-10-15(27-4)14(26-3)9-12(13)16(19)21-18/h9-11H,5-8H2,1-4H3,(H2,19,20,21)
    Key: YEOTYALSMRNXLJ-UHFFFAOYSA-N
  • CC(C(=O)N1CCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC)OC
Properties
C18H25N5O4
Molar mass 375.429 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Synthesis

edit
 
ChemDrug Synthesis:[3] Patent:[4]
  • 2-methoxypropionylchloride [56680-75-2] (2)
  • 2-Methoxy-1-(piperazin-1-yl)propan-1-one [95550-01-9] (3)
  • 4-Amino-2-chloro-6,7-dimethoxyquinazoline [23680-84-4] (4)

References

edit
  1. ^ Trcka, V; König, J; Mácová, S; Smíd, M; Helfert, I; Votavová, M; Remesová, J; Nezádalová, E (1990). "Pharmacology of a new antihypertensive agent, metazosin (Kenosin)". Ceskoslovenska Farmacie. 39 (6): 266–74. PMID 1981860.
  2. ^ Lapka, R; Rejholec, V; Sechser, T; Peterková, M; Smíd, M (1989). "Interspecies pharmacokinetic scaling of metazosin, a novel alpha-adrenergic antagonist". Biopharmaceutics & Drug Disposition. 10 (6): 581–9. doi:10.1002/bdd.2510100607. PMID 2575403.
  3. ^ Smd, M.; Trcka, V.; Knig, J.; METAZOSIN. Drugs Fut 1990, 15, 7, 680.
  4. ^ DE3419223, idem Jan Dipl Ing Koenig, Miroslav Dipl Ing Rajsner,Vaclav Trcka, Svetluse Macova, U.S. patent 4,775,673 (1984 to Spofa Spojene Tovarny Pro Zdra).